Code | 6261C | ||||||||||
MA number | EU/1/06/356/020 | ||||||||||
Product Form: | gra sac 30x90 mg (vre.PET/Al/PE) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Novartis Europharm Limited, Ireland | ||||||||||
Therapeutic Class: | 19 - ANTIDOTA, DETOXICANTIA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application |
MA issued: | 10.11.2017 |
SmPC + PL: |
|
Dokument: |
|
Dokument: |
|
Dokument: |
|
Safety feature | Yes |
Data update: | 18.06.2018 |